搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
11 小时
TSMC, Tradeweb And Another IBD 50 Name Struggle With Breakouts
Tradeweb Markets broke out of a newly formed stage-two flat base with a 136.13 buy point on Nov. 20, but failed to climb and ...
1 天
Boston Scientific, IBD Stock Of The Day, Has Surged 57% In 2024. This Is Why There's More ...
How to protect against high-pressure marketing tactics.
腾讯网
3 天
中山六院左涛课题组揭示肠道噬菌体移植可缓解炎症性肠病间发性 ...
Science & Technology近日,我院左涛研究员和高翔主任医师团队合作在Gut(IF=23.0)在线发表题为“Fecal phageome transplantation alleviates intermittent ...
Investor's Business Daily on MSN
12 小时
Wix.com, IBD Stock Of The Day, Pivots To Interactive AI Products
Wix.com is the IBD Stock Of The Day amid the website builder's 81% share gain in 2024. Strong institutional support is a ...
Investor's Business Daily on MSN
14 小时
Atlantic Union Bankshares Sees IBD RS Rating Rise To 72
Atlantic Union Bankshares shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...
10 天
on MSN
Teva Soars, Sanofi Gains on Strong Trial Results for IBD Treatment
Duvakitug was generally well tolerated across patient groups and showed similar rates of treatment-emergent adverse events, ...
腾讯网
10 天
近半溃疡性结肠炎患者达缓解!赛诺菲/梯瓦潜在“best-in-class”疗法 ...
Duvakitug(曾用名TEV’574)是一款潜在“best-in-class”的人源IgG1-λ2单抗,靶向TL1A,又称肿瘤坏死因子(TNF)超家族成员15。TL1A通过与其受体DR3结合,可放大炎症反应并加速IBD相关纤维化的进展。靶向TL1 ...
biopharma-reporter
10 天
Teva and Sanofi’s IBD drug hits Phase 2 targets
The anti-TL1A antibody allowed significantly more inflammatory bowel disease (IBD) patients to go into remission than those ...
news.stocktradersdaily
13 天
(IBD) Trading Signals
GET MORE AI-GENERATED SIGNALS: December 15, 2024, 01:48 am ET, BY Tom S.- Contributor| Editor: Thomas H. Kee Jr. ( Follow on ...
FierceBiotech
10 天
Sanofi, Teva look to 'next frontier' in IBD treatment after TL1A antibody hits mark in ...
As Merck and Roche continue to march their respective inflammatory bowel disease (IBD) assets through the clinic, Sanofi and ...
10 天
Teva Stock Soars 19% as Game-Changing IBD Drug Duvakitug Crushes Trial Expectations
Teva Pharmaceutical Industries and Sanofi (NASDAQ:SNY) just dropped a game-changing update for investorstheir star drug ...
7 天
on MSN
IBD vs SD Champion Ka Tashan: Yo Yo Honey Singh interrupts Remo's challenge, 'I don’t ...
In a thrilling episode of India’s Best Dancer vs Super Dancer: Champion Ka Tashan, Yo Yo Honey Singh interrupts a dance ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈